Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Add like
Add dislike
Add to saved papers

Follicle stimulating hormone binding inhibiting activity and inhibin properties of human ovarian cystic and porcine follicular fluid.

Ovarian cystic fluid was obtained from 13 regularly cycling women with the operative diagnosis of ovarian serous (n = 6), mucinous cystadenomas (n = 3) and simple follicular cysts (n = 4). The effects of the fluids, after steroid extraction with charcoal treatment, on the binding of follicle stimulating hormone (FSH) to rat testicular homogenates and on the in vitro secretion of FSH and luteinizing hormone (LH) by rat pituitary cell preparations were studied. Similar studies were conducted simultaneously with steroid-free porcine follicular fluid (pFF). Human ovarian cystic fluids produced a marked inhibition of FSH-binding activity in the absence of an effect on FSH or LH secretion. In contrast, pFF exhibited both FSH-binding inhibitory (FSH-BI) and inhibin activities. Furthermore, heating did not alter the FSH-BI activity nor the inhibin properties of steroid-free human ovarian cystic fluids nor porcine follicular fluid.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app